Clinical trial · NCT06423963
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Summary
The purpose of the study is to examine the feasibility and acceptability of an exercise and nutrition "prehabilitation" program for patients preparing for pancreatic cancer resection (removal).
Interventions
- Physical Activity · BEHAVIORAL
Each participant will receive a Fitbit device with instruction and encouragement to self-monitor physical activity using step counts.
- Nutrition Counseling · BEHAVIORAL
Participants will receive nutritional counseling with a registered dietician.
- Resistance Training · BEHAVIORAL
Participants will engage in progressive, full-body resistance training based on American College of Sports Medicine (ACSM) guidelines.
Published eligibility criteria
Verbatim from the registry. Only the site can decide how these apply to a specific patient.
Inclusion Criteria: * Age 18 years or older * Biopsy-proven pancreatic ductal adenocarcinoma (PDAC), borderline resectable at diagnosis * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 * Undergoing neoadjuvant chemotherapy with treatment plan including chemoradiation therapy and surgical resection * Ability to read and speak English Exclusion Criteria: * Regular engagement in RT (2x/week targeting all major muscle groups) * Screen failure for exercise safety based on PAR-Q * Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease * Recent fracture or acute musculoskeletal injury that precludes ability to participate in RT * Numeric pain rating scale greater than or equal to a 7 out of 10 * Myopathic or rheumatologic disease that impacts physical function
Sites (1)
- Moffitt Cancer Center, Tampa, Florida · Recruiting
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-09-15.